JSF Financial’s ALX Oncology ALXO Stock Holding History

JSF Financial’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$24.3K	Hold	17,500	–	–	﹤0.01%	145
2026 Q2	$36.2K	Hold	17,500	–	–	0.01%	141
2026 Q1	$35.1K	Hold	17,500	–	–	0.01%	126
2025 Q4	$19.8K	Hold	17,500	–	–	﹤0.01%	132
2025 Q3	$32K	Hold	17,500	–	–	0.01%	128
2025 Q2	$7.26K	Hold	17,500	–	–	﹤0.01%	128
2025 Q1	$10.9K	Hold	17,500	–	–	﹤0.01%	120
2024 Q4	$29.2K	Buy	+17,500	New	+$26.9K	0.01%	121

Other funds holding ALXO

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Lido Advisors Los Angeles, California $39.1B AUM 20.96% 1-Year Est. Return

JSF Financial's ALXO Position: Q3 2026 in Review

JSF Financial held its ALX Oncology (ALXO) position steady in Q3 2026 at 17,500 shares worth $24.3K. The position accounts for ﹤0.01% of the portfolio, ranked #145.

JSF Financial first reported a position in ALXO in Q4 2024 and has held it in 8 quarters since. The position peaked at $36.2K in Q2 2026. 26 funds tracked by Wall St. Rank hold ALXO as of Q3 2026.

JSF Financial held 17,500 shares of ALX Oncology worth $24.3K as of Q3 2026.
JSF Financial left its ALX Oncology share count unchanged in Q3 2026.
ALX Oncology made up ﹤0.01% of JSF Financial's portfolio in Q3 2026, its #145 holding.
JSF Financial first reported a position in ALX Oncology in Q4 2024 and has held it in 8 quarters since.
JSF Financial's ALX Oncology position peaked at $36.2K in Q2 2026.
26 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2026.

Based on JSF Financial's 13F filing for Q3 2026, filed 22 Oct 2026.